Daniela Matei, MD
Enriched profileDirector, Houston Methodist Dr. Mary and Ron Neal Cancer Center; Acting Professor of Medicine, Houston Methodist Academic Institute; CPRIT Scholar in Cancer Research · Houston Methodist Dr. Mary and Ron Neal Cancer Center
Daniela Matei is Director, Houston Methodist Dr. Mary and Ron Neal Cancer Center; Acting Professor of Medicine, Houston Methodist Academic Institute; CPRIT Scholar in Cancer Research at Houston Methodist Dr. Mary and Ron Neal Cancer Center. OpenAlex indexes 572 publications with 21,094 citations (h-index 71); ClinicalTrials.gov lists 13 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Hematology / Oncology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Daniela Matei, MD, is Director, Houston Methodist Dr. Mary and Ron Neal Cancer Center. The public record shows 572 publications with 21,094 citations (h-index 71), centered on Ovarian cancer diagnosis and treatment, Epigenetics and DNA Methylation, Blood properties and coagulation. It also documents an investigator role on 13 registered clinical trials, industry payments reported by 11 companies, 9 NIH-funded awards (2016–2026).
- Top research focus: Ovarian cancer diagnosis and treatment
- 13 registered trials on ClinicalTrials.gov
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 24 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 161.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:
- Guadecitabine and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Sponsor: Northwestern University
- Pembro/Carbo/Taxol in Endometrial Cancer
Sponsor: Daniela Matei, MD
Industry payments
Updated 27 Aug 2026
11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- TAIHO ONCOLOGY, INC.Program year20254 payments
- AstraZeneca Pharmaceuticals LPProgram year20254 payments
- Merck Sharp & Dohme LLCProgram year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
53.9%Microtubule Inhibitor51.9%Paclitaxel100%Part B, office-administered≥19 patientsPlatinum-based Drug2.1%Carboplatin100%Part B, office-administered≥19 patientsMetabolism & gastrointestinal
41.6%Other antiemetics39.1%Fosaprepitant100%Part B, office-administered≥22 patientsSerotonin-3 Receptor Antagonist2.4%Palonosetron hcl100%Part B, office-administered≥22 patientsSensory organs
4.2%Corticosteroid4.2%Dexamethasone sodium phosphate100%Part B, office-administered≥29 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
9 NIH research awards on record, funded 2016–2026 per NIH RePORTER. The latest:
- Northwestern University Center for Chromatin NanoImaging in Cancer (NU-CCNIC)
Northwestern University
FY2026$1,590,459U54CA268084 - Northwestern University Lead Academic Participating Site
Northwestern University
FY2026$1,139,381UG1CA308665 - Lipid Unsaturation Drives Ovarian Cancer Progression
Methodist Hospital Research Institute
FY2026$641,081R01CA224275
Congress activity
Updated 27 Aug 2026
92 congress contributions (2005–2026) across AACR, ASCO, ASTRO, ESMO, SABCS per OpenAlex. The most recent:
- Abstract 4582: Targeting MEIS2 in platinum resistant ovarian cancer
AACR Annual Meeting
AACR2026Co-author - Abstract 7485: RNA modification control of platinum sensitivity via ADAM23-dependent pathway
AACR Annual Meeting
AACR2026Co-author - Abstract 1536: Unsaturated fatty acids promote cell cycle progression and proliferation of platinum resistant ovarian cancer cells
AACR Annual Meeting
AACR2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Most-cited works
by citation count (OpenAlex)- 01Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian CancerArticle1,901 citations2012
- 02
- 03Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human TumorsArticle1,310 citations2008
- 04Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyArticle725 citations2021
- 05Lipid Desaturation Is a Metabolic Marker and Therapeutic Target of Ovarian Cancer Stem CellsArticle599 citations2016
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- LinkedIn
linkedin.com/in/daniela-matei-818780314
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Daniela-Matei-2146146540
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - ResearchGate
researchgate.net/scientific-contributions/Daniela-Matei-2175620318
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Instagram
instagram.com/p/DYTdPEesyFp
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com ↗ - Other
breakthroughsforphysicians.nm.org/obgyn-clinical-podcast-ovarian-cancer-treatment-matei.html
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →breakthroughsforphysicians.nm.org ↗ - Other
endofound.org/-/daniela-matei
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endofound.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Fellowship
Hematology and Medical Oncology, UCLA David Geffen School of Medicine / Ronald Reagan UCLA Medical Center
2002verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →feinberg.northwestern.edu ↗ - Fellowship in Hematology and Medical Oncology
UCLA David Geffen School of Medicine/UCLA Medical Center
2002provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →providers.sharecare.com ↗ - Fellowship
Hematology and Medical Oncology, UCLA David Geffen School of Medicine / UCLA Medical Center
2002provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →feinberg.northwestern.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →feinberg.northwestern.edu ↗
- Board Certified
Medical Oncology (American Board of Internal Medicine)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - M.D.
Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →houstonmethodist.org ↗ - Postgraduate medical training
SUNY at Stony Brook
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →houstonmethodist.org ↗ - Board certified
Medical Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →providers.sharecare.com ↗ - MD
University of Medicine and Pharmacy "Carol Davila," Bucharest, Romania
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →houstonmethodist.org ↗ - Board certified
Medical Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →care.healthline.com ↗ - MD
Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →houstonmethodist.org ↗ - Internal medicine residency
SUNY Stony Brook (State University of New York at Stony Brook)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗ - Hematology-oncology fellowship
UCLA (University of California, Los Angeles)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗
Editorial & leadership roles
journal and society appointments- Committee member (past two decades)
National Cancer Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →houstonmethodist.org ↗ - Committee member
American Society of Clinical Oncology (ASCO)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →houstonmethodist.org ↗ - Committee member
Ovarian Cancer NCI Taskforce
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →houstonmethodist.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →news.northwestern.edu ↗
- CPRIT (Cancer Prevention and Research Institute of Texas) Recruitment of Established Investigator Award
$4 million, supporting her recruitment to Houston Methodist
2026verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →houstonmethodist.org ↗ - Cancer Prevention and Research Institute of Texas (CPRIT) Recruitment of Established Investigator (REI) Award
$4 million, tied to Houston Methodist recruitment
2026verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →houstonmethodist.org ↗
Secondary affiliations
appointments beyond the home institution- Adjunct Lecturer
Department of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine
2026verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →feinberg.northwestern.edu ↗ - Former: Chief
Division of Reproductive Science in Medicine, Dept. of Obstetrics & Gynecology, Northwestern University Feinberg School of Medicine
2026verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →houstonmethodist.org ↗ - Northwestern University Feinberg School of Medicine
Department of Obstetrics and Gynecology -- former Chief, Division of Reproductive Science in Medicine
2026verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →feinberg.northwestern.edu ↗
Media & interviews
press, podcasts and appearances- News feature on her appointment to lead Houston Methodist Neal Cancer Center
syndicated via EurekAlert and multiple regional outlets
2026verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →houstonmethodist.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →breakthroughsforphysicians.nm.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.northwestern.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Sameer Gopalani, MD
Oak Ridge Associated Universities
Baha Sibai, MD
Memorial Hermann
Robert Coleman, MD
Vaniam Group
Kathleen Moore, MD
University of Nebraska Medical Center